Company Qingdao Vland Biotech INC.

Equities

603739

CNE100003GX8

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Qingdao Vland Biotech INC.

EPS Revisions

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
10.13 ^CNY	+3.16%		+11.93%	-33.44%

2023	Qingdao Vland Biotech INC. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	Qingdao Vland Biotech Forms Chinese JV With Germany’s Evonik	MT

Qingdao Vland Biotech Co., Ltd. is a China-based company which mainly develops, produces and sells enzyme preparations, micro-ecology and animal health products. The Company's main products are enzyme preparations, micro-ecology and animal health products, such as feed enzymes, industrial enzymes, food enzymes, plant micro-ecological preparations, veterinary chemicals and veterinary drugs. The Company's products are mainly used in the washing, textile, food, feed, paper, energy and pharmaceutical industries. The Company mainly distributes its products in China and overseas markets.

Number of employees: 1,590

CNY in Million	2021	Weight	2022	Weight	Delta
Enzyme 36.3 %	430	37.4 %	422	36.3 %	-1.98%
Animal Health 25.7 %	324	28.2 %	299	25.7 %	-7.73%
Microecology 21.6 %	250	21.7 %	251	21.6 %	+0.45%
Others 14.0 %	106	9.2 %	163	14.0 %	+53.57%
Other Business 2.4 %	40	3.5 %	28	2.4 %	-29.80%

CNY in Million	2021	Weight	2022	Weight	Delta
China 92.3 %	1,023	92.2 %	1,047	92.3 %	+2.35%
Overseas 7.7 %	87	7.8 %	87	7.7 %	+0.41%

Managers	Title	Age	Since
Gang Chen CEO	Chief Executive Officer	49	14-05-11
Pi Yuan Qiao DFI	Director of Finance/CFO	47	17-05-19
Bing Liang Huang BRD	Director/Board Member	69	17-05-19
Shu Jun You IRC	Investor Relations Contact	-	-
Yong Jiang SEC	Corporate Secretary	44	19-03-21

Members of the board	Title	Age	Since
Bing Liang Huang BRD	Director/Board Member	69	17-05-19
De Qiang Jia BRD	Director/Board Member	54	11-05-19
Pi Yuan Qiao DFI	Director of Finance/CFO	47	17-05-19
Gang Chen CEO	Chief Executive Officer	49	14-05-11
Jing Wang BRD	Director/Board Member	37	23-05-16
Ying Ting Lin BRD	Director/Board Member	62	20-05-18
Yu Yuan CHM	Chairman	44	20-05-18
Jing Shao BRD	Director/Board Member	40	20-05-18
Rui Feng Song BRD	Director/Board Member	39	20-05-18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	253,028,866	81,898,806 ( 32.37 %)	0	32.37 %

Name	Equities	%	Valuation
Da Cheng Fund Management Co., Ltd. 2.350 %	5,088,966	2.350 %	8 M ¥
Penghua Fund Management Co., Ltd. 0.3862 %	836,240	0.3862 %	1 M ¥
Gfund Management Co., Ltd. 0.0446 %	96,600	0.0446 %	153 171 ¥
JPMorgan Asset Management (China) Co Ltd. 0.002263 %	4,900	0.002263 %	7 770 ¥
Sealand Securities Co., Ltd. (Investment Management) 0.000785 %	1,700	0.000785 %	2 696 ¥
Truvalue Asset Management Co. Ltd. 0.000139 %	300	0.000139 %	476 ¥

Qingdao Vland Biotech Co., Ltd.

No. 596-1 Jiushui East Road Laoshan District

266100, Qingdao

http://www.vlandgroup.com

address Qingdao Vland Biotech INC.(603739)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.13

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
QINGDAO VLAND BIOTECH INC.	-33.44%	354M
VERTEX PHARMACEUTICALS INCORPORATED	-0.49%	105B
REGENERON PHARMACEUTICALS, INC.	+3.31%	97.5B
ARGENX SE	+1.66%	22.19B
BIONTECH SE	-16.16%	21.33B
GENMAB A/S	-6.82%	18.68B
WUXI APPTEC CO., LTD.	-41.41%	16.6B
BEIGENE, LTD.	-22.87%	14.52B
NEUROCRINE BIOSCIENCES, INC.	+6.32%	14.09B
SAREPTA THERAPEUTICS, INC.	+21.46%	10.99B

Bio Therapeutic Drugs